Profile
AGRX ZTS TAK HLN TEVA NBIX
Company Name Agile Therapeutics, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $10.43M $63.86B $42.85B $42.64B $28.05B $15.29B
Employees 0.02K 13.80K 49.28K 24.56K 37.00K 1.80K
CEO Alfred F. Altomari Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Kyle W. Gano
Ratings
AGRX ZTS TAK HLN TEVA NBIX
Quant Rating Score 2 3 3 3 3 4
Quant Rating Sell Neutral Neutral Neutral Neutral Buy
Trading
AGRX ZTS TAK HLN TEVA NBIX
Last Close $1.51 $119.56 $13.64 $9.41 $24.46 $154.8
High 52 $1.51 $178.71 $15.52 $11.41 $24.6 $154.8
Low 52 $1.51 $119.56 $12.89 $8.73 $12.82 $87.59
Price vs. 52 Week High 0 % -33.1 % -12.11 % -17.53 % -0.57 % 0 %
Price vs. 52 Week Low 0 % 0 % 5.82 % 7.79 % 90.8 % 76.73 %
Total Return
AGRX ZTS TAK HLN TEVA NBIX
1 Month Return 0 % -16.26 % -5.64 % 6.69 % 21.87 % 12.99 %
3 Month Return 0 % -19.32 % -5.05 % -0.58 % 50.15 % 23.21 %
6 Month Return 0 % -23.31 % -9.43 % -12.59 % 38.98 % 27.23 %
9 Month Return 0 % -30.26 % 0.81 % -1.47 % 45.16 % 26.89 %
YTD Return 0 % -26.62 % 3.02 % -1.36 % 10.98 % 13.41 %
1 Year Return 0 % -31.39 % -1.59 % -1.98 % 39.77 % 24.86 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AGRX ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.34 % 4.72 % 1.57 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.89 % 2.01 % 2.01 % 2.78 % 14.57 %
Dividend Per Share (TTM) - 1.93 % 198 % 0.06 % - -
Payout Ratio (TTM) - 32.08 % 226.17 % 27.27 % - -
Profitability
AGRX ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 54.18 % 70.03 % 52.77 % 61.81 % 49.6 % 98.37 %
Return on Assets TTM -141.05 % 18.04 % 0.98 % 4.78 % -0.39 % 10.03 %
Return on Equity TTM 132.32 % 53.21 % 1.95 % 9.4 % -2.58 % 15.82 %
Return on Capital Employed TTM 188.98 % 31.67 % 4.8 % 8.34 % 3.16 % 15.17 %
Net Income Per EBT TTM 100 % 78.72 % 72.4 % 76.52 % 222.54 % 68.09 %
EBT Per Ebit TTM 72.75 % 94.26 % 33.29 % 88.09 % -7.94 % 114.25 %
EBIT Per Revenue TTM -101.49 % 37.51 % 12.68 % 20.49 % 5.38 % 20.51 %
Cash Flow To Debt Ratio TTM -440.93 % 43.13 % 22.35 % 12.02 % 7.93 % 148.65 %
Receivables Turnover TTM 5.78 6.09 6.59 5.14 4.67 3.69
Payables Turnover TTM 0.94 5.54 5.02 1.18 3.35 0.37
Inventory Turnover TTM 3.28 1.15 1.71 3.72 2.4 0.63
Fixed Asset Turnover TTM 4023.2 % 244.46 % 229.02 % 589.57 % 321.73 % 473.81 %
Asset Turnover TTM 191.06 % 64.82 % 31.99 % 34.62 % 41.43 % 62.89 %
Operating Cash Flow Per Share TTM -4.44 6.58 643.53 0.11 1.21 6.41
Free Cash Flow Per Share TTM -4.44 4.99 521.29 0.1 0.78 5.97
Cash Per Share TTM 118.56 % 322.4 % 22368.59 % 7.46 % 188.4 % 1121.53 %
Operating Cash Flow Sales Ratio TTM -48.88 % 31.21 % 22.48 % 9.32 % 8.36 % 23.74 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 75.76 % 81.01 % 90.65 % 64.03 % 93.14 %
Cash Flow Coverage Ratios TTM -440.93 % 43.13 % 22.35 % 12.02 % 7.93 % 148.65 %
Price To Free Cash Flows Ratio TTM -1.09 28.78 8.1 34.18 31.29 25.77
Price To Operating Cash Flows Ratio TTM -0.34 21.9 6.51 31.51 20.03 24
Price Cash Flow Ratio TTM -0.34 21.9 6.51 31.51 20.03 24
Income Statement (TTM)
AGRX ZTS TAK HLN TEVA NBIX
Revenue $0.02B $9.26B $4581.55B $11.23B $16.54B $2.36B
Gross Profit $0.01B $6.4B $3001.33B $6.95B $8.06B $2.32B
Gross Profit Ratio 54.18% 69.1% 65.51% 61.85% 48.74% 98.56%
EBITDA $-0.02B $3.87B $1210.51B $2.51B $0.78B $0.64B
Net Income $-0.01B $2.49B $107.93B $1.44B $-1.64B $0.34B
EPS Diluted -6.71 5.47 33.62 0.32 -1.45 3.29
Balance Sheet (MRQ)
AGRX ZTS TAK HLN TEVA NBIX
Long Term Debt $0B $5.39B $4517.23B $8.62B $16.3B $0.46B
Total Liabilities $0.03B $9.47B $7312.37B $18.09B $33.61B $1.13B
Total Equity $-0.02B $4.77B $6935.98B $16.22B $5.72B $2.59B
Total Investments $0B $0.03B $382.4B $0.08B $0B $1.71B
Total Debt $0B $6.74B $5066.17B $10.1B $18.08B $0.46B
Total Assets $0.01B $14.24B $14248.34B $34.32B $39.33B $3.72B
Cash Flow Statement (TTM)
AGRX ZTS TAK HLN TEVA NBIX
Net Income $-0.01B $2.5B $107.93B $1.44B $-1.96B $0.34B
Inventory $-0B $-0.04B $-34.97B $0.22B $0.17B $-0.02B
Dividends Paid $0B $-0.79B $-302.5B $-0.57B $0B $0B
Operating Cash Flow $-0.01B $2.95B $1057.18B $2.3B $1.25B $0.6B
Capital Expenditure $0B $-0.66B $-200.8B $-0.25B $-0.5B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.555
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AKAN Akanda Corp. 1.315
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 5.705
ALVOW Alvotech 0.78
AMPH Amphastar Pharmaceuticals, Inc. 24.04
AMRX Amneal Pharmaceuticals, Inc. 11.37
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 90.49
APUS Apimeds Pharmaceuticals US, Inc 2.2899
AQST Aquestive Therapeutics, Inc. 6.045
ASRT Assertio Holdings, Inc. 0.7609
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 18.7
AYTU Aytu BioPharma, Inc. 2.03
ETFs With Exposure to AGRX
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 146.48
VXF Vanguard Extended Market Index Fund 0 207.9
VQNPX Vanguard Growth and Income Fund 0 72.2
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 117.85
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 156.17
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 156.18
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
VEMPX Vanguard Extended Market Index InstlPlus 0 385.39
Unlock